Concepts (315)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cognitive Dysfunction | 28 | 2025 | 739 | 4.530 |
Why?
|
| Healthy Lifestyle | 10 | 2024 | 36 | 3.380 |
Why?
|
| Cardiovascular Diseases | 16 | 2025 | 293 | 3.230 |
Why?
|
| Alzheimer Disease | 13 | 2025 | 1323 | 3.090 |
Why?
|
| Life Expectancy | 9 | 2022 | 24 | 2.370 |
Why?
|
| Diet, Mediterranean | 10 | 2024 | 63 | 2.260 |
Why?
|
| Obesity | 10 | 2020 | 294 | 2.240 |
Why?
|
| Aged | 62 | 2025 | 7586 | 1.900 |
Why?
|
| Body Mass Index | 13 | 2024 | 403 | 1.770 |
Why?
|
| Prospective Studies | 31 | 2025 | 1535 | 1.730 |
Why?
|
| Female | 66 | 2025 | 13266 | 1.640 |
Why?
|
| Risk Factors | 31 | 2025 | 1997 | 1.630 |
Why?
|
| Humans | 91 | 2025 | 23569 | 1.570 |
Why?
|
| Male | 58 | 2025 | 12776 | 1.560 |
Why?
|
| Apolipoprotein E4 | 8 | 2025 | 174 | 1.550 |
Why?
|
| Exercise | 13 | 2022 | 400 | 1.540 |
Why?
|
| Cognition | 15 | 2024 | 948 | 1.420 |
Why?
|
| Diabetes Mellitus, Type 2 | 7 | 2024 | 148 | 1.340 |
Why?
|
| Netherlands | 18 | 2024 | 26 | 1.310 |
Why?
|
| Aging | 11 | 2025 | 1101 | 1.230 |
Why?
|
| Independent Living | 6 | 2025 | 225 | 1.150 |
Why?
|
| Cohort Studies | 21 | 2025 | 1466 | 1.150 |
Why?
|
| Pediatric Obesity | 2 | 2018 | 43 | 1.090 |
Why?
|
| Mothers | 2 | 2018 | 160 | 1.000 |
Why?
|
| Stroke | 5 | 2023 | 244 | 0.980 |
Why?
|
| Neurodegenerative Diseases | 6 | 2025 | 96 | 0.920 |
Why?
|
| Chicago | 16 | 2025 | 818 | 0.890 |
Why?
|
| Aged, 80 and over | 23 | 2025 | 3770 | 0.890 |
Why?
|
| Waist Circumference | 4 | 2016 | 35 | 0.850 |
Why?
|
| Middle Aged | 30 | 2024 | 8155 | 0.820 |
Why?
|
| Dementia | 6 | 2024 | 390 | 0.820 |
Why?
|
| Vitamin D | 2 | 2022 | 29 | 0.800 |
Why?
|
| DNA Methylation | 6 | 2021 | 129 | 0.780 |
Why?
|
| Risk Assessment | 7 | 2024 | 556 | 0.740 |
Why?
|
| Longitudinal Studies | 10 | 2025 | 1050 | 0.730 |
Why?
|
| Overweight | 5 | 2021 | 68 | 0.710 |
Why?
|
| Blood Pressure | 3 | 2024 | 169 | 0.710 |
Why?
|
| Epigenomics | 4 | 2021 | 11 | 0.700 |
Why?
|
| Brain | 6 | 2024 | 1215 | 0.690 |
Why?
|
| Menopause | 5 | 2024 | 99 | 0.680 |
Why?
|
| United States | 9 | 2024 | 1837 | 0.650 |
Why?
|
| Dietary Approaches To Stop Hypertension | 4 | 2024 | 24 | 0.640 |
Why?
|
| Incidence | 9 | 2025 | 644 | 0.600 |
Why?
|
| Amino Acyl-tRNA Synthetases | 1 | 2018 | 1 | 0.590 |
Why?
|
| RNA-Binding Proteins | 1 | 2018 | 19 | 0.580 |
Why?
|
| Metabolic Syndrome | 2 | 2016 | 55 | 0.580 |
Why?
|
| Mortality | 2 | 2016 | 74 | 0.580 |
Why?
|
| Preconception Care | 1 | 2018 | 1 | 0.570 |
Why?
|
| Patient Compliance | 1 | 2018 | 146 | 0.530 |
Why?
|
| Lipids | 3 | 2025 | 45 | 0.530 |
Why?
|
| Biomarkers | 8 | 2025 | 482 | 0.530 |
Why?
|
| Proportional Hazards Models | 8 | 2024 | 276 | 0.510 |
Why?
|
| Life Style | 4 | 2022 | 160 | 0.510 |
Why?
|
| Neurofilament Proteins | 3 | 2025 | 16 | 0.510 |
Why?
|
| Obesity, Metabolically Benign | 1 | 2016 | 1 | 0.500 |
Why?
|
| Body Composition | 1 | 2016 | 66 | 0.480 |
Why?
|
| tau Proteins | 3 | 2025 | 148 | 0.480 |
Why?
|
| Anthropometry | 1 | 2015 | 29 | 0.470 |
Why?
|
| Alleles | 4 | 2024 | 164 | 0.470 |
Why?
|
| Somatotypes | 1 | 2014 | 2 | 0.460 |
Why?
|
| Follow-Up Studies | 5 | 2024 | 1493 | 0.440 |
Why?
|
| Genome-Wide Association Study | 5 | 2022 | 152 | 0.390 |
Why?
|
| Postmenopause | 3 | 2018 | 57 | 0.380 |
Why?
|
| Carotid Intima-Media Thickness | 3 | 2022 | 17 | 0.370 |
Why?
|
| Diet | 5 | 2024 | 182 | 0.370 |
Why?
|
| Adult | 11 | 2024 | 7178 | 0.370 |
Why?
|
| Risk Reduction Behavior | 4 | 2020 | 36 | 0.370 |
Why?
|
| Environmental Exposure | 2 | 2024 | 18 | 0.360 |
Why?
|
| Air Pollution | 2 | 2024 | 14 | 0.360 |
Why?
|
| CpG Islands | 4 | 2021 | 43 | 0.350 |
Why?
|
| Alcohol Drinking | 4 | 2020 | 70 | 0.350 |
Why?
|
| Atherosclerosis | 3 | 2022 | 44 | 0.350 |
Why?
|
| White Matter | 2 | 2022 | 109 | 0.350 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2021 | 261 | 0.330 |
Why?
|
| Surveys and Questionnaires | 5 | 2024 | 1046 | 0.320 |
Why?
|
| Apolipoproteins E | 4 | 2023 | 143 | 0.300 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 79 | 0.300 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 83 | 0.300 |
Why?
|
| Pandemics | 2 | 2020 | 207 | 0.300 |
Why?
|
| Population Surveillance | 2 | 2021 | 107 | 0.290 |
Why?
|
| Intermediate Filaments | 3 | 2023 | 19 | 0.290 |
Why?
|
| Coronary Disease | 2 | 2018 | 49 | 0.280 |
Why?
|
| Glial Fibrillary Acidic Protein | 2 | 2025 | 38 | 0.280 |
Why?
|
| Body Size | 2 | 2019 | 6 | 0.280 |
Why?
|
| Adolescent | 4 | 2024 | 1953 | 0.270 |
Why?
|
| Dietary Supplements | 3 | 2022 | 55 | 0.270 |
Why?
|
| Lipid Metabolism | 2 | 2017 | 33 | 0.270 |
Why?
|
| Child | 3 | 2024 | 1178 | 0.260 |
Why?
|
| Estrogen Receptor beta | 2 | 2016 | 4 | 0.250 |
Why?
|
| Prevalence | 3 | 2023 | 395 | 0.250 |
Why?
|
| Amyloid beta-Peptides | 2 | 2024 | 199 | 0.240 |
Why?
|
| Sex Factors | 5 | 2020 | 393 | 0.240 |
Why?
|
| Epigenesis, Genetic | 4 | 2021 | 61 | 0.240 |
Why?
|
| Waist-Hip Ratio | 2 | 2015 | 12 | 0.230 |
Why?
|
| Coronary Artery Disease | 2 | 2017 | 124 | 0.230 |
Why?
|
| Coffee | 1 | 2024 | 3 | 0.230 |
Why?
|
| Vehicle Emissions | 1 | 2024 | 5 | 0.230 |
Why?
|
| Social Isolation | 1 | 2025 | 19 | 0.230 |
Why?
|
| Beverages | 1 | 2024 | 12 | 0.230 |
Why?
|
| Air Pollutants | 1 | 2024 | 11 | 0.230 |
Why?
|
| Particulate Matter | 1 | 2024 | 16 | 0.230 |
Why?
|
| Loneliness | 1 | 2025 | 42 | 0.220 |
Why?
|
| Weight Gain | 3 | 2024 | 59 | 0.210 |
Why?
|
| Dietary Fats | 1 | 2024 | 38 | 0.210 |
Why?
|
| Whole Grains | 1 | 2023 | 4 | 0.210 |
Why?
|
| Memory Disorders | 1 | 2024 | 106 | 0.210 |
Why?
|
| Florida | 1 | 2023 | 17 | 0.210 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2021 | 167 | 0.210 |
Why?
|
| Flavonols | 1 | 2022 | 5 | 0.200 |
Why?
|
| Anti-Mullerian Hormone | 1 | 2022 | 2 | 0.200 |
Why?
|
| Vitamin E | 1 | 2023 | 37 | 0.200 |
Why?
|
| Time Factors | 7 | 2021 | 1295 | 0.200 |
Why?
|
| Vitamins | 1 | 2022 | 14 | 0.190 |
Why?
|
| Betacoronavirus | 2 | 2020 | 69 | 0.190 |
Why?
|
| Comorbidity | 3 | 2022 | 431 | 0.190 |
Why?
|
| Smoking | 3 | 2020 | 168 | 0.190 |
Why?
|
| Gastrointestinal Diseases | 1 | 2022 | 27 | 0.180 |
Why?
|
| Lutein | 1 | 2021 | 3 | 0.180 |
Why?
|
| Zeaxanthins | 1 | 2021 | 3 | 0.180 |
Why?
|
| Carotenoids | 1 | 2021 | 14 | 0.180 |
Why?
|
| Survivors | 1 | 2022 | 68 | 0.180 |
Why?
|
| Diet Surveys | 1 | 2021 | 23 | 0.180 |
Why?
|
| Lipoproteins, HDL | 1 | 2021 | 23 | 0.180 |
Why?
|
| Leukocytes | 1 | 2021 | 31 | 0.180 |
Why?
|
| Health Status | 2 | 2019 | 203 | 0.180 |
Why?
|
| Neuropsychological Tests | 2 | 2021 | 867 | 0.180 |
Why?
|
| Nurses | 2 | 2018 | 42 | 0.170 |
Why?
|
| Diet, Western | 1 | 2021 | 7 | 0.170 |
Why?
|
| Amyloid | 1 | 2021 | 39 | 0.170 |
Why?
|
| Body Weight | 2 | 2018 | 129 | 0.170 |
Why?
|
| Weight Loss | 2 | 2020 | 122 | 0.170 |
Why?
|
| Eczema | 1 | 2020 | 3 | 0.170 |
Why?
|
| Lipase | 1 | 2020 | 4 | 0.170 |
Why?
|
| Phenotype | 2 | 2018 | 261 | 0.170 |
Why?
|
| Membrane Proteins | 1 | 2021 | 151 | 0.170 |
Why?
|
| Rhinitis, Allergic | 1 | 2020 | 14 | 0.170 |
Why?
|
| Geriatric Assessment | 1 | 2021 | 159 | 0.170 |
Why?
|
| Dyslipidemias | 2 | 2019 | 15 | 0.170 |
Why?
|
| Pancreas | 1 | 2020 | 30 | 0.160 |
Why?
|
| Diabetes Mellitus | 2 | 2019 | 110 | 0.160 |
Why?
|
| Food Hypersensitivity | 1 | 2020 | 40 | 0.160 |
Why?
|
| Neoplasms | 2 | 2020 | 223 | 0.160 |
Why?
|
| Autopsy | 1 | 2021 | 257 | 0.160 |
Why?
|
| Sex Hormone-Binding Globulin | 2 | 2018 | 16 | 0.160 |
Why?
|
| Inbreeding Depression | 1 | 2019 | 1 | 0.160 |
Why?
|
| Consanguinity | 1 | 2019 | 2 | 0.160 |
Why?
|
| Fertility | 1 | 2019 | 17 | 0.160 |
Why?
|
| Cholesterol, HDL | 2 | 2016 | 26 | 0.160 |
Why?
|
| Risk-Taking | 1 | 2019 | 28 | 0.160 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2019 | 31 | 0.150 |
Why?
|
| Ventricular Function, Left | 1 | 2019 | 34 | 0.150 |
Why?
|
| Socioeconomic Factors | 2 | 2019 | 271 | 0.150 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2018 | 4 | 0.150 |
Why?
|
| Antioxidants | 1 | 2018 | 56 | 0.140 |
Why?
|
| Androgens | 1 | 2018 | 7 | 0.140 |
Why?
|
| Insulin Resistance | 2 | 2017 | 48 | 0.140 |
Why?
|
| Predictive Value of Tests | 2 | 2021 | 443 | 0.140 |
Why?
|
| Asthma | 1 | 2020 | 153 | 0.140 |
Why?
|
| Lung Diseases | 1 | 2018 | 43 | 0.140 |
Why?
|
| Endocrine Disruptors | 1 | 2018 | 1 | 0.140 |
Why?
|
| Child Behavior | 1 | 2018 | 28 | 0.140 |
Why?
|
| Basal Metabolism | 1 | 2018 | 7 | 0.140 |
Why?
|
| Mother-Child Relations | 1 | 2018 | 28 | 0.140 |
Why?
|
| Fluorocarbons | 1 | 2018 | 11 | 0.140 |
Why?
|
| Testosterone | 1 | 2018 | 27 | 0.140 |
Why?
|
| Diet, Reducing | 1 | 2018 | 12 | 0.140 |
Why?
|
| Thiocyanates | 1 | 2017 | 4 | 0.140 |
Why?
|
| Perchlorates | 1 | 2017 | 5 | 0.140 |
Why?
|
| Nitrates | 1 | 2017 | 9 | 0.140 |
Why?
|
| Hospitalization | 1 | 2020 | 293 | 0.140 |
Why?
|
| Thyroid Function Tests | 1 | 2017 | 12 | 0.140 |
Why?
|
| Vascular Calcification | 1 | 2017 | 9 | 0.140 |
Why?
|
| gamma-Glutamyltransferase | 1 | 2017 | 1 | 0.140 |
Why?
|
| Amino Acid Transport System y+ | 1 | 2017 | 1 | 0.140 |
Why?
|
| Health Personnel | 1 | 2018 | 87 | 0.140 |
Why?
|
| Aspartate Aminotransferases | 1 | 2017 | 14 | 0.130 |
Why?
|
| Protective Factors | 4 | 2018 | 20 | 0.130 |
Why?
|
| Alanine Transaminase | 1 | 2017 | 15 | 0.130 |
Why?
|
| Fatty Liver | 1 | 2017 | 26 | 0.130 |
Why?
|
| Cognition Disorders | 1 | 2022 | 690 | 0.130 |
Why?
|
| Pregnancy | 1 | 2018 | 322 | 0.130 |
Why?
|
| Transportation | 1 | 2016 | 4 | 0.130 |
Why?
|
| Inhalation Exposure | 1 | 2016 | 5 | 0.130 |
Why?
|
| Histones | 1 | 2016 | 28 | 0.130 |
Why?
|
| Actigraphy | 1 | 2016 | 80 | 0.130 |
Why?
|
| Primary Prevention | 1 | 2016 | 23 | 0.130 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2016 | 5 | 0.130 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2016 | 9 | 0.130 |
Why?
|
| Case-Control Studies | 1 | 2017 | 505 | 0.120 |
Why?
|
| Cross-Sectional Studies | 4 | 2021 | 778 | 0.120 |
Why?
|
| Child, Preschool | 1 | 2018 | 583 | 0.120 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2016 | 7 | 0.120 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2016 | 6 | 0.120 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2016 | 43 | 0.120 |
Why?
|
| Waist-Height Ratio | 1 | 2015 | 5 | 0.120 |
Why?
|
| Adipose Tissue | 1 | 2016 | 73 | 0.120 |
Why?
|
| Cause of Death | 3 | 2022 | 58 | 0.120 |
Why?
|
| Health Behavior | 1 | 2016 | 149 | 0.110 |
Why?
|
| Sweating | 1 | 2014 | 2 | 0.110 |
Why?
|
| Hot Flashes | 1 | 2014 | 11 | 0.110 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 244 | 0.110 |
Why?
|
| Perimenopause | 1 | 2014 | 14 | 0.110 |
Why?
|
| Copper | 2 | 2024 | 14 | 0.110 |
Why?
|
| Sensitivity and Specificity | 1 | 2014 | 453 | 0.100 |
Why?
|
| Risk | 3 | 2018 | 164 | 0.100 |
Why?
|
| Prognosis | 1 | 2015 | 749 | 0.100 |
Why?
|
| Age Factors | 3 | 2022 | 648 | 0.100 |
Why?
|
| Multivariate Analysis | 3 | 2018 | 299 | 0.100 |
Why?
|
| Triglycerides | 2 | 2025 | 54 | 0.090 |
Why?
|
| Cholesterol | 2 | 2025 | 57 | 0.090 |
Why?
|
| Genotype | 2 | 2024 | 249 | 0.090 |
Why?
|
| Quantitative Trait Loci | 2 | 2021 | 26 | 0.080 |
Why?
|
| Carnitine O-Palmitoyltransferase | 2 | 2021 | 2 | 0.080 |
Why?
|
| Educational Status | 2 | 2021 | 214 | 0.080 |
Why?
|
| Nutrition Surveys | 2 | 2018 | 23 | 0.070 |
Why?
|
| Walking | 2 | 2021 | 237 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2016 | 254 | 0.060 |
Why?
|
| Switzerland | 1 | 2024 | 8 | 0.060 |
Why?
|
| Nitrogen Dioxide | 1 | 2024 | 4 | 0.060 |
Why?
|
| Nitrogen Oxides | 1 | 2024 | 4 | 0.060 |
Why?
|
| Tea | 1 | 2024 | 4 | 0.060 |
Why?
|
| Bayes Theorem | 1 | 2024 | 33 | 0.060 |
Why?
|
| Food Handling | 1 | 2024 | 2 | 0.060 |
Why?
|
| Fast Foods | 1 | 2024 | 5 | 0.060 |
Why?
|
| Heterozygote | 1 | 2025 | 89 | 0.060 |
Why?
|
| Zinc | 1 | 2024 | 39 | 0.060 |
Why?
|
| Energy Intake | 1 | 2024 | 77 | 0.050 |
Why?
|
| Feeding Behavior | 1 | 2024 | 79 | 0.050 |
Why?
|
| Diet, Sodium-Restricted | 1 | 2023 | 7 | 0.050 |
Why?
|
| Caloric Restriction | 1 | 2023 | 11 | 0.050 |
Why?
|
| Hypertension | 1 | 2024 | 163 | 0.050 |
Why?
|
| Tocopherols | 1 | 2023 | 8 | 0.050 |
Why?
|
| alpha-Tocopherol | 1 | 2023 | 11 | 0.050 |
Why?
|
| Quercetin | 1 | 2022 | 5 | 0.050 |
Why?
|
| Kaempferols | 1 | 2022 | 6 | 0.050 |
Why?
|
| Diet, Vegetarian | 1 | 2022 | 5 | 0.050 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2022 | 22 | 0.050 |
Why?
|
| Brain Infarction | 1 | 2023 | 63 | 0.050 |
Why?
|
| Eating | 1 | 2022 | 46 | 0.050 |
Why?
|
| Memory, Short-Term | 1 | 2022 | 79 | 0.050 |
Why?
|
| Biological Specimen Banks | 1 | 2022 | 5 | 0.050 |
Why?
|
| United Kingdom | 1 | 2022 | 41 | 0.050 |
Why?
|
| Mental Status and Dementia Tests | 1 | 2022 | 42 | 0.050 |
Why?
|
| Vegetables | 1 | 2021 | 22 | 0.050 |
Why?
|
| Gene Expression | 1 | 2022 | 179 | 0.040 |
Why?
|
| Accelerometry | 1 | 2021 | 78 | 0.040 |
Why?
|
| Executive Function | 1 | 2021 | 89 | 0.040 |
Why?
|
| Music Therapy | 1 | 2020 | 2 | 0.040 |
Why?
|
| Intubation | 1 | 2020 | 6 | 0.040 |
Why?
|
| Meditation | 1 | 2020 | 21 | 0.040 |
Why?
|
| Symptom Assessment | 1 | 2020 | 17 | 0.040 |
Why?
|
| Homozygote | 1 | 2019 | 13 | 0.040 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2020 | 72 | 0.040 |
Why?
|
| Haplotypes | 1 | 2019 | 41 | 0.040 |
Why?
|
| Nursing Research | 1 | 2020 | 33 | 0.040 |
Why?
|
| Disease Management | 1 | 2020 | 100 | 0.040 |
Why?
|
| Diastole | 1 | 2019 | 28 | 0.040 |
Why?
|
| ADAMTS9 Protein | 1 | 2018 | 1 | 0.040 |
Why?
|
| Protein-Lysine 6-Oxidase | 1 | 2018 | 2 | 0.040 |
Why?
|
| Amino Acid Oxidoreductases | 1 | 2018 | 2 | 0.040 |
Why?
|
| Lod Score | 1 | 2018 | 11 | 0.040 |
Why?
|
| Age of Onset | 1 | 2019 | 73 | 0.040 |
Why?
|
| Animals | 2 | 2016 | 3311 | 0.040 |
Why?
|
| Dehydroepiandrosterone | 1 | 2018 | 4 | 0.040 |
Why?
|
| Blood Glucose | 1 | 2019 | 99 | 0.040 |
Why?
|
| Androstenedione | 1 | 2018 | 6 | 0.040 |
Why?
|
| Rest | 1 | 2018 | 27 | 0.040 |
Why?
|
| Symporters | 1 | 2017 | 5 | 0.040 |
Why?
|
| Life Tables | 1 | 2017 | 5 | 0.040 |
Why?
|
| Clinical Trials as Topic | 1 | 2018 | 196 | 0.030 |
Why?
|
| Amino Acid Transport System ASC | 1 | 2017 | 1 | 0.030 |
Why?
|
| Amino Acid Transport System y+L | 1 | 2017 | 1 | 0.030 |
Why?
|
| Phosphoglycerate Dehydrogenase | 1 | 2017 | 1 | 0.030 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2017 | 3 | 0.030 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2017 | 5 | 0.030 |
Why?
|
| RNA Interference | 1 | 2017 | 36 | 0.030 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2017 | 1 | 0.030 |
Why?
|
| Transfection | 1 | 2017 | 117 | 0.030 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2017 | 2 | 0.030 |
Why?
|
| Neoplasm Proteins | 1 | 2017 | 52 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 819 | 0.030 |
Why?
|
| Histone Code | 1 | 2016 | 1 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2018 | 316 | 0.030 |
Why?
|
| ATP Binding Cassette Transporter 1 | 1 | 2016 | 2 | 0.030 |
Why?
|
| Bias | 1 | 2016 | 24 | 0.030 |
Why?
|
| Logistic Models | 1 | 2017 | 357 | 0.030 |
Why?
|
| Genome, Human | 1 | 2016 | 34 | 0.030 |
Why?
|
| Cholesterol, LDL | 1 | 2016 | 29 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2017 | 230 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2016 | 47 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2017 | 248 | 0.030 |
Why?
|
| Membrane Glycoproteins | 1 | 2016 | 50 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2017 | 168 | 0.030 |
Why?
|
| Health | 1 | 2016 | 9 | 0.030 |
Why?
|
| Gardening | 1 | 2016 | 1 | 0.030 |
Why?
|
| Bicycling | 1 | 2016 | 4 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2016 | 89 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 2017 | 129 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2016 | 131 | 0.030 |
Why?
|
| Arteries | 1 | 2016 | 13 | 0.030 |
Why?
|
| Cardiology | 1 | 2016 | 45 | 0.030 |
Why?
|
| Sports | 1 | 2016 | 42 | 0.030 |
Why?
|
| Cell Membrane Permeability | 1 | 2016 | 51 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2016 | 73 | 0.030 |
Why?
|
| Cell Movement | 1 | 2016 | 77 | 0.030 |
Why?
|
| Anxiety | 1 | 2016 | 142 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2016 | 165 | 0.030 |
Why?
|
| Depressive Disorder | 1 | 2016 | 163 | 0.030 |
Why?
|
| Calcium | 1 | 2018 | 356 | 0.030 |
Why?
|
| Inflammation | 1 | 2016 | 237 | 0.030 |
Why?
|
| Vasomotor System | 1 | 2014 | 3 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2017 | 606 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2016 | 402 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2020 | 3095 | 0.020 |
Why?
|
| Parkinson Disease | 1 | 2016 | 592 | 0.020 |
Why?
|